RLAY — Relay Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Relay Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	678	958	999	750	781
Net Total Accounts Receivable
Net Total Receivables	82.7	4.94	5.22	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	770	976	1,020	770	809
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	28.8	27.3	75.4	68.9	57.7
Net Intangible Assets
Other Long Term Assets
Total Assets	800	1,008	1,100	844	871
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	13.6	24.3	63.7	30.3	50.7
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	36.5	111	150	92	93.5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	763	898	950	752	778
Total Liabilities & Shareholders' Equity	800	1,008	1,100	844	871
Total Common Shares Outstanding